Home » Topics » BioWorld Science

BioWorld Science
RSS

New lipid nanoparticles allow mRNA delivery to the lung for treating lymphangioleiomyomatosis

March 9, 2022

Zinc oxide nanoparticles target integrin alpha-v beta-3 for breast cancer treatment

March 9, 2022

TNIK Therapeutics presents new prodrugs of TNIK inhibitors

March 9, 2022

P2RX3 antagonists discovered at Tuojie Biotech

March 9, 2022

Nanjing Shunxin Pharmaceutical, Jiangsu Chia Tai Tianqing Pharmaceutical Group patent ADCs

March 9, 2022

New ibuprofen derivatives divulged by Nanjing Heron Pharmaceutical Science and Technology

March 9, 2022

Abbisko Therapeutics identifies new EGFR inhibitors

March 9, 2022

Ixaka's CELTIC-19 targeted nanoparticle product granted ATMP classification

March 8, 2022

Sunshine Lake Pharma researchers describe JAK inhibitors

March 8, 2022

Dana-Farber Cancer Institute patents USP28 inhibitors for cancer

March 8, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 6, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...
Bio Korea 2026: US policy risks shift to execution framework
BioWorld
Regulatory uncertainty that dominated the life science sector in 2025 is transitioning into an execution framework for biotechnology companies, provided companies...
Regulatory actions for May 5, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Adma, Applied...